| Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes | 09/23 09:29 | prnewswire.com |
| Genprex Announces Formation of Mesothelioma Clinical Advisory Board | 09/19 09:29 | prnewswire.com |
| Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics | 09/09 09:29 | prnewswire.com |
| Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes | 09/04 09:29 | prnewswire.com |
| Genprex to Present and Participate at Upcoming September Investor and Industry Conferences | 09/03 08:15 | prnewswire.com |
| Genprex Releases New Video Featuring Chief Medical Officer Discussing Positive Patient Outcomes in Two Lung Cancer Clinical Trials | 08/15 09:30 | prnewswire.com |
| Genprex Announces Positive Clinical Study Updates from Acclaim-1 and Acclaim-3 Phase 1/2 Clinical Trials in Lung Cancer | 08/14 09:25 | prnewswire.com |
| Genprex Granted Patent in Singapore for Reqorsa® Gene Therapy with PD-1 Antibodies to Treat Cancers | 08/13 08:31 | prnewswire.com |
| Genprex to Present at the August Sidoti Microcap Conference | 08/08 08:30 | prnewswire.com |
| Genprex Issues Stockholder Letter and Provides 2024 Corporate Update | 06/27 08:31 | prnewswire.com |